IVD Market in the Middle East, 2018 Report

The "The IVD Market in the
This report on the Middle East IVD in the last five years finds the
Many Middle Eastern countries, such as
The region's public sector has historically dominated the delivery of healthcare in the
Some of the total IVD market growth derives from increased test usage in emerging countries. All of the major IVD companies have reported growth in
This development requires increased investment in healthcare. This increased investment most often takes the form of government tenders, which remain a major source of supply for state-controlled labs and hospitals. Lifestyle change a more sedentary lifestyle resulting in rising obesity rates has brought about the emergence of Western diseases such as diabetes. There is growing demand in the region, therefore, for medical tests.
This report provides an overview of developments in the in vitro diagnostics industry in the
The countries covered are:
Egypt Iran Iraq Israel Jordan Saudi Arabia Turkey United Arab Emirates (UAE )- Other
Middle East
The
The report covers six segments of the IVD market in the
- Clinical Chemistry
- Immunoassays
- Microbiology
- Point of Care (POC)
- Histology
- Other
The next five to ten years will see moderate and gradual change in global in vitro diagnostic (IVD) product markets. While clinical lab medicine plays an integral role in healthcare and disease management, new testing is difficult to launch in a time of global economic instability and rising healthcare costs. On the supply side, labs are challenged to add new tests with little increase in financial and human resources.
IVD companies are casting their nets in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care.
Key Topics Covered:
1. Executive Summary
- Overview
- Scope and Methodology
- Size and Growth of the Market
2.
- Population
- Economic Outlook
- Major Diseases Affecting the Middle Eastern Population
- Cardiovascular Diseases
- Cancer
- Diabetes
- Middle Eastern Respiratory Syndrome (MERS)
Arab Health Congress
3. Country Market Analysis
4. Market Summary: Total Middle East Market
- Summary
- Clinical Chemistry Market
- Immunoassay Market
- Microbiology Market
- Point-of-Care Market
- Histology Market
For more information about this report visit https://www.researchandmarkets.com/research/pbhqrx/ivd_market_in_the?w=5
Media Contact:
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For
For GMT Office Hours Call +353-1-416-8900
Fax (outside
View original content with multimedia:http://www.prnewswire.com/news-releases/ivd-market-in-the-middle-east-2018-report-300700823.html
SOURCE



Fundraiser aids soldier’s family dealing with flood aftermath
Advisor News
- Addressing the ‘menopause tax:’ A guide for advisors with female clients
- Alternative investments in 401(k)s: What advisors must know
- The modern advisor: Merging income, insurance, and investments
- Financial shocks, caregiving gaps and inflation pressures persist
- Americans unprepared for increased longevity
More Advisor NewsAnnuity News
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Aspida Life and WealthVest Offer a Powerful New Guaranteed Income Product with the WealthLock® Income Builder
- Lack of digital tools drives wedge between insurers, advisors
- LIMRA: Annuity sales notch 10th consecutive $100B+ quarter
- AIG to sell remaining shares in Corebridge Financial
More Annuity NewsHealth/Employee Benefits News
- We can't afford to let Democrats lead health care 'reform' | Opinion
- Expanding Medicaid coverage lowered death rates for young adults with kidney failure
- GLP-1s: Rewriting the relationship between pharmacy benefits and stop-loss
- Studies from Denise Wolff et al Have Provided New Data on Atopic Dermatitis (AMCP Market Insights: Beyond skin deep on the role of managed care in moderate to severe atopic dermatitis): Skin Diseases and Conditions – Atopic Dermatitis
- New Clinical Trials and Studies Findings from RAND Corporation Described (Benefit design and consumer information: results from a randomized trial): Clinical Research – Clinical Trials and Studies
More Health/Employee Benefits NewsLife Insurance News
- 3 ways AI can help close the gap for women’s insurance coverage
- Best’s Market Segment Report: AM Best Revises Outlook on Italy’s Life Insurance Segment to Stable From Negative
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Dan Scholz to receive NAIFA’s Terry Headley Lifetime Defender Award
- Best’s Special Report: US Property/Casualty and Health Insurers Exceed Cost of Capital; Life Insurers Narrowly Miss
More Life Insurance News